Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

August 20th 2020


BONE THERAPEUTICS today announces it has received EUR 0.6 million in grants from the Walloon Region (Belgium) for research and initial preparatory steps towards clinical development of BT-20, its new allogeneic and off-the-shelf cell therapy product. Please discover the press release here.